Role of Mammary Epithelial and Stromal P450 Enzymes in the Clearance and Metabolic Activation of 7,12-dimethylbenz(a)anthracene in Mice

Overview

Journal Toxicol Lett

Publisher Elsevier

Specialty Toxicology

Date 2012 May 19

PMID 22595614

Citations 15

Authors

Yang Lin

Yunyi Yao

Senyan Liu

Lihua Wang

Bhagavatula Moorthy

Dongsheng Xiong

Tao Cheng

Xinxin Ding

Jun Gu

Affiliations

Soon will be listed here.

Abstract

Microsomal cytochrome P450 (P450) enzymes, which are important in the metabolism of carcinogens, are expressed in both epithelial and stromal cells in the mammary gland. The aim of this study was to investigate the roles of mammary epithelial P450 enzymes in the bioactivation and disposition of 7,12-dimethylbenz(a)anthracene (DMBA), a breast carcinogen, in the mammary gland. A new mouse model (named MEpi-Cpr-null) was produced, wherein P450 activities in the mammary epithelial cells are suppressed through tissue-specific deletion of the gene for P450 reductase (Cpr), an enzyme required for the activities of all microsomal P450 enzymes. Comparisons between wild-type and MEpi-Cpr-null mice showed that the tissue-specific deletion of Cpr in the mammary epithelial cells was accompanied by significant increases in the levels of DMBA and DMBA-DNA adduct in the mammary gland following a single intraperitoneal injection of DMBA at 50mg/kg. Immunohistochemical and immunoblot analysis further revealed greater induction of CYP1B1 expression by the DMBA treatment in the mammary stroma of the MEpi-Cpr-null mice than in that of the WT mice. These findings not only demonstrate that the epithelial P450 enzymes play important roles in the clearance of DMBA, but also suggest that P450 enzymes in both mammary epithelial and stromal cells contribute to carcinogen-mediated DNA damage.

Citing Articles

Rat Models of Breast Cancer.

Bu W, Li Y Adv Exp Med Biol. 2025; 1464():123-148.

PMID: 39821024 DOI: 10.1007/978-3-031-70875-6_8.

Exposure to brominated flame retardants and through lactation delays the development of DMBA-induced mammary cancer: potential effects on subtypes?.

Juarez M, McDermott A, Wade M, Plante I Front Endocrinol (Lausanne). 2024; 15:1429142.

PMID: 39610845 PMC: 11602300. DOI: 10.3389/fendo.2024.1429142.

Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging.

Mehata A, Singh V, Vikas , Srivastava P, Koch B, Kumar M Nanotheranostics. 2024; 8(2):179-201.

PMID: 38444739 PMC: 10911970. DOI: 10.7150/ntno.94364.

Exploring the Protective Effect against 7,12-Dimethylbenz[a]anthracene-Induced Breast Tumors of Palmitoylethanolamide.

Rai N, Kailashiya V, Gautam V ACS Pharmacol Transl Sci. 2024; 7(1):97-109.

PMID: 38230286 PMC: 10789129. DOI: 10.1021/acsptsci.3c00188.

Assessing cytochrome P450 function using genetically engineered mouse models.

Hannon S, Ding X Adv Pharmacol. 2022; 95:253-284.

PMID: 35953157 PMC: 10544722. DOI: 10.1016/bs.apha.2022.05.008.

References

Fang C, Behr M, Xie F, Lu S, Doret M, Luo H . Mechanism of chloroform-induced renal toxicity: non-involvement of hepatic cytochrome P450-dependent metabolism. Toxicol Appl Pharmacol. 2007; 227(1):48-55. PMC: 2274901. DOI: 10.1016/j.taap.2007.10.014. View

Gu J, Chen C, Wei Y, Fang C, Xie F, Kannan K . A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition. J Pharmacol Exp Ther. 2007; 321(1):9-17. DOI: 10.1124/jpet.106.118240. View

Pass G, Carrie D, Boylan M, Lorimore S, Wright E, Houston B . Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse. Cancer Res. 2005; 65(10):4211-7. DOI: 10.1158/0008-5472.CAN-04-4103. View

Zhang Q, Fang C, Zhang J, Dunbar D, Kaminsky L, Ding X . An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine. Drug Metab Dispos. 2008; 37(3):651-7. PMC: 2645477. DOI: 10.1124/dmd.108.025429. View

Li D, Wang M, Firozi P, Chang P, Zhang W, Baer-Dubowska W . Characterization of a major aromatic DNA adduct detected in human breast tissues. Environ Mol Mutagen. 2002; 39(2-3):193-200. DOI: 10.1002/em.10063. View

Arif J, Smith W, Gupta R . Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene. Mutat Res. 1997; 378(1-2):31-9. DOI: 10.1016/s0027-5107(97)00095-x. View

Perera F, Estabrook A, Hewer A, Channing K, Rundle A, Mooney L . Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev. 1995; 4(3):233-8. View

Hellmold H, Magnusson M, Pelto-Huikko M, Rylander T, Gustafsson J, Warner M . Identification of CYP2A3 as a major cytochrome P450 enzyme in the female peripubertal rat breast. Mol Pharmacol. 1998; 53(3):475-82. DOI: 10.1124/mol.53.3.475. View

Galvan N, Teske D, Zhou G, Moorthy B, MacWilliams P, Czuprynski C . Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity. Toxicol Appl Pharmacol. 2005; 202(3):244-57. DOI: 10.1016/j.taap.2004.06.026. View

10.

Cui Y, Miyoshi K, Claudio E, Siebenlist U, Gonzalez F, Flaws J . Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem. 2002; 277(20):17830-5. DOI: 10.1074/jbc.M200186200. View

11.

Sharma D, Smits B, Eichelberg M, Meilahn A, Muelbl M, Haag J . Quantification of epithelial cell differentiation in mammary glands and carcinomas from DMBA- and MNU-exposed rats. PLoS One. 2011; 6(10):e26145. PMC: 3192144. DOI: 10.1371/journal.pone.0026145. View

12.

Kleiner H, Vulimiri S, Hatten W, Reed M, Nebert D, Jefcoate C . Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis. Chem Res Toxicol. 2004; 17(12):1667-74. DOI: 10.1021/tx049919c. View

13.

Zhang Q, Kaminsky L, Dunbar D, Zhang J, Ding X . Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine. Drug Metab Dispos. 2007; 35(9):1617-23. DOI: 10.1124/dmd.107.016543. View

14.

Izzotti A, Camoirano A, Cartiglia C, Grubbs C, Lubet R, Kelloff G . Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents. Cancer Res. 1999; 59(17):4285-90. View

15.

Gu J, Weng Y, Zhang Q, Cui H, Behr M, Wu L . Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem. 2003; 278(28):25895-901. DOI: 10.1074/jbc.M303125200. View

16.

Black S, Coon M . P-450 cytochromes: structure and function. Adv Enzymol Relat Areas Mol Biol. 1987; 60:35-87. DOI: 10.1002/9780470123065.ch2. View

17.

Feng Y, Manka D, Wagner K, Khan S . Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci U S A. 2007; 104(37):14718-23. PMC: 1976199. DOI: 10.1073/pnas.0706933104. View

18.

Todorovic R, Ariese F, Devanesan P, Jankowiak R, Small G, Rogan E . Determination of benzo[a]pyrene- and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem Res Toxicol. 1997; 10(9):941-7. DOI: 10.1021/tx970003y. View

19.

Gupta R . Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A. 1984; 81(22):6943-7. PMC: 392052. DOI: 10.1073/pnas.81.22.6943. View

20.

Fang C, Gu J, Xie F, Behr M, Yang W, Abel E . Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. Drug Metab Dispos. 2008; 36(8):1722-8. PMC: 2575052. DOI: 10.1124/dmd.108.021881. View